Basic Information
Redwood Pharma AB is dedicated to developing new ophthalmic therapies to meet unmet market needs. The product under development is a novel treatment for chronic dry eye disease (DED) in postmenopausal women.
Redwood Pharma AB
Stockholm,Stockholm,Sweden
15~50 people
February 12, 2012
martin.vidaeus@redwoodpharma.com
Enterprise Profile
Industrial Sector
Concept
Application Scenarios